FiercePharma

Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR

DUBLIN, May 22, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a December 15, 2014 ...
Medscape

Memantine: A Treatment for Alzheimer's Disease With a New Formulation

† Noted adverse events were experienced in ≥5% of either treatment group, and had an incidence more than or equal to twice as great in memantine-treated patients than in placebo-treated patients. AE: ...
FiercePharma

Actavis and Adamas Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride

- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS ...
Sickle Cell Disease News

Alzheimer’s drug memantine may help prevent SCD crises, especially in kids

Memantine, a cheaply available drug used for decades to treat Alzheimer's, may help prevent sickle cell crises, especially in ...
Business Wire

Miller Law LLC and Safirstein Law LLC Announce Proposed Settlements in the Namenda Indirect Purchaser Antitrust Litigation

CHICAGO--(BUSINESS WIRE)--If You Purchased, Paid for, or Provided Reimbursement for the Alzheimer’s Disease Drug Namenda XR or Namenda IR and its AB-rated generic equivalents, between April 14, 2010 ...
Healthline

Namenda Interactions: Alcohol, Medications, and Others

Namenda (memantine) is a prescription drug that’s used to treat dementia related to Alzheimer’s disease. This drug can interact with other medications and some supplements. For example, Namenda can ...
ascopubs.org

Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma.

Association of anticonvulsant prophylaxis in patients with primary and metastatic brain tumors and 1-year overall survival: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from ...
Pharmabiz

US FDA approves Namzaric, a FDC of memantine ER and donepezil HCl

Actavis and Adamas Pharmaceuticals Inc announced that the US Food and Drug Administration (US FDA) has approved the New Drug Application (NDA) for Namzaric, a fixed-dose combination (FDC) of memantine ...
FierceBiotech

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type NEW YORK, Jun 21, 2010 (BUSINESS WIRE ...
Nature

Cholinesterase inhibitors potentiate memantine neurotoxicity

Memantine, a specific N-methyl-D-aspartate (NMDA) antagonist, and cholinesterase inhibitors, such as donepezil, are widely prescribed to patients with Alzheimer's disease, often in combination. NMDA ...
Medscape

Memantine: A Treatment for Alzheimer's Disease With a New Formulation

Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe AD as ...